Guardant Health (GH) News Today $49.30 +0.01 (+0.02%) Closing price 04:00 PM EasternExtended Trading$49.50 +0.20 (+0.41%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GH Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Mizuho Forecasts Strong Price Appreciation for Guardant Health (NASDAQ:GH) StockJune 15 at 2:14 AM | americanbankingnews.comGuardant Health (NASDAQ:GH) Price Target Raised to $65.00Mizuho lifted their target price on Guardant Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a research note on Friday.June 13 at 1:43 PM | marketbeat.comRhumbline Advisers Has $7.47 Million Stake in Guardant Health, Inc. (NASDAQ:GH)Rhumbline Advisers grew its position in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 4.9% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 175,432 shares of the company's stock after buying an additional 8,2June 12, 2025 | marketbeat.com2 Mooning Stocks Worth Your Attention and 1 to Be Wary OfJune 11, 2025 | finance.yahoo.comAmirali Talasaz Sells 39,751 Shares of Guardant Health, Inc. (NASDAQ:GH) StockJune 11, 2025 | americanbankingnews.comGuardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer ScreeningJune 10, 2025 | finance.yahoo.comGuardant Health Wins Fast Company's 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer ScreeningJune 10, 2025 | businesswire.comGuardant Health, Inc. (NASDAQ:GH) CEO Amirali Talasaz Sells 1,680 SharesJune 10, 2025 | insidertrades.comGuardant Health, Inc. (NASDAQ:GH) CEO Amirali Talasaz Sells 1,680 SharesGuardant Health, Inc. (NASDAQ:GH - Get Free Report) CEO Amirali Talasaz sold 1,680 shares of the stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $50.00, for a total value of $84,000.00. Following the sale, the chief executive officer now owns 2,187,060 shares in the company, valued at approximately $109,353,000. This represents a 0.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.June 9, 2025 | marketbeat.comGuardant Health, Inc. (NASDAQ:GH) CEO Sells $1,990,332.57 in StockGuardant Health, Inc. (NASDAQ:GH - Get Free Report) CEO Amirali Talasaz sold 39,751 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $50.07, for a total transaction of $1,990,332.57. Following the transaction, the chief executive officer now owns 2,147,309 shares of the company's stock, valued at approximately $107,515,761.63. This trade represents a 1.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.June 9, 2025 | marketbeat.comGuardant Health, Inc. (NASDAQ:GH) CEO Amirali Talasaz Sells 77,853 SharesGuardant Health, Inc. (NASDAQ:GH - Get Free Report) CEO Amirali Talasaz sold 77,853 shares of the business's stock in a transaction on Monday, June 9th. The shares were sold at an average price of $50.09, for a total transaction of $3,899,656.77. Following the sale, the chief executive officer now directly owns 2,069,456 shares of the company's stock, valued at $103,659,051.04. This represents a 3.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.June 9, 2025 | marketbeat.comNew Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast CancerJune 9, 2025 | businesswire.comGAMMA Investing LLC Acquires 17,530 Shares of Guardant Health, Inc. (NASDAQ:GH)GAMMA Investing LLC lifted its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 11,765.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,679 shares of the company's stock after acJune 9, 2025 | marketbeat.comGuardant Health, Inc. (NASDAQ:GH) Receives Consensus Rating of "Buy" from AnalystsJune 9, 2025 | americanbankingnews.comGuardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of "Buy" by AnalystsShares of Guardant Health, Inc. (NASDAQ:GH - Get Free Report) have been assigned an average recommendation of "Buy" from the twenty-one analysts that are covering the stock, MarketBeat Ratings reports. Twenty analysts have rated the stock with a buy rating and one has given a strong buy rating toJune 9, 2025 | marketbeat.comMRA Advisory Group Invests $651,000 in Guardant Health, Inc. (NASDAQ:GH)MRA Advisory Group purchased a new position in Guardant Health, Inc. (NASDAQ:GH - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 15,275 shares of the company's stock, valued at approximately $651,000. Other large investors haJune 6, 2025 | marketbeat.comGuardant Health, Inc. (NASDAQ:GH) Short Interest Up 18.3% in MayGuardant Health, Inc. (NASDAQ:GH - Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 9,120,000 shares, an increase of 18.3% from the April 30th total of 7,710,000 shares. Based on an average trading volume of 2,220,000 shares, the days-to-cover ratio is currently 4.1 days. Currently, 7.8% of the shares of the stock are sold short.June 5, 2025 | marketbeat.comWhy Guardant Health Stock Surged Nearly 9% Higher TodayJune 3, 2025 | fool.comGuardant Health shares rise following FDA breakthrough designationJune 3, 2025 | investing.comFDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (MCD) TestJune 3, 2025 | finance.yahoo.comGuardant Health Shares Climb on FDA Breakthrough Status for Cancer Detection TestJune 3, 2025 | msn.comCathie Wood’s ARK buys Guardant Health, sells Adaptive Biotechnologies stockJune 2, 2025 | investing.comGuardant Health Joins Rank Of Stocks With RS Ratings Over 90June 2, 2025 | msn.comGuardant Health announces NCCN has included Shield blood test in CRC guidelinesJune 2, 2025 | msn.comNational Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based ScreeningJune 2, 2025 | businesswire.com111 Capital Buys New Holdings in Guardant Health, Inc. (NASDAQ:GH)111 Capital bought a new stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,303 shares of the company's stock, valued at approximately $254,0June 1, 2025 | marketbeat.comGuardant Health, Inc. (GH)’s ctDNA Test Predicts Colon Cancer Recurrence Risk in Stage III PatientsMay 31, 2025 | insidermonkey.comGuardant Health (NASDAQ:GH) Shares Up 4.5% - Still a Buy?Guardant Health (NASDAQ:GH) Trading Up 4.5% - Still a Buy?May 31, 2025 | marketbeat.comIn Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Timely Treatment DecisionsMay 31, 2025 | businesswire.comGuardant Health, Inc. (NASDAQ:GH) Shares Sold by Nuveen Asset Management LLCNuveen Asset Management LLC cut its stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 22.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 321,242 shares of the company's stock after selling 90,508 shares durMay 29, 2025 | marketbeat.comGuardant Health, Inc. (GH) Expands Liquid Biopsy to Pinpoint Tumor Origins and BiomarkersMay 29, 2025 | insidermonkey.comFiring on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the WayMay 28, 2025 | finance.yahoo.comGuardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid TestMay 27, 2025 | businesswire.comPolar Asset Management Partners Inc. Has $13.89 Million Holdings in Guardant Health, Inc. (NASDAQ:GH)Polar Asset Management Partners Inc. raised its position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 1,902.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 454,500 shares of the compaMay 27, 2025 | marketbeat.comGuardant Health, Inc. (NASDAQ:GH) Position Trimmed by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 30.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owMay 27, 2025 | marketbeat.comAmeriprise Financial Inc. Purchases 76,124 Shares of Guardant Health, Inc. (NASDAQ:GH)Ameriprise Financial Inc. raised its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 96.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 155,165 shares of the company's stock aMay 26, 2025 | marketbeat.comVoloridge Investment Management LLC Sells 65,585 Shares of Guardant Health, Inc. (NASDAQ:GH)Voloridge Investment Management LLC lowered its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 9.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 596,682 shares of the company's stock after seMay 25, 2025 | marketbeat.comTwinbeech Capital LP Makes New Investment in Guardant Health, Inc. (NASDAQ:GH)Twinbeech Capital LP purchased a new position in Guardant Health, Inc. (NASDAQ:GH - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,001 shares of the company's stock,May 25, 2025 | marketbeat.comGuardant Health, Inc. (NASDAQ:GH) Shares Acquired by ProShare Advisors LLCProShare Advisors LLC increased its position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 30.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,594 shares of the company's stock after acqMay 25, 2025 | marketbeat.comGuardant Health, Inc. (NASDAQ:GH) Stock Position Lessened by Gotham Asset Management LLCGotham Asset Management LLC decreased its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 48.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,821 shares of the company's stock after selling 7,357 shares duMay 24, 2025 | marketbeat.comGuardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual MeetingMay 22, 2025 | businesswire.comTwo Sigma Advisers LP Boosts Holdings in Guardant Health, Inc. (NASDAQ:GH)Two Sigma Advisers LP increased its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 96.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,315,600 shares of the company's stock after buyingMay 22, 2025 | marketbeat.comTwo Sigma Investments LP Purchases 525,368 Shares of Guardant Health, Inc. (NASDAQ:GH)Two Sigma Investments LP lifted its position in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 38.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,890,714 shares of the company's stock after buying an additiMay 22, 2025 | marketbeat.com8,134 Shares in Guardant Health, Inc. (NASDAQ:GH) Purchased by Sherbrooke Park Advisers LLCSherbrooke Park Advisers LLC acquired a new position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 8,134 shares of the company's stock, valued at approximatelyMay 22, 2025 | marketbeat.comFocus Partners Wealth Buys Shares of 17,896 Guardant Health, Inc. (NASDAQ:GH)Focus Partners Wealth bought a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 17,896 shares of the company's stock, valued at approximatMay 22, 2025 | marketbeat.comGuardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid TumorsMay 21, 2025 | finance.yahoo.comGuardant Health (GH) introduces IHC Solid Tumor Testing to its PortfolioMay 21, 2025 | insidermonkey.com20,800 Shares in Guardant Health, Inc. (NASDAQ:GH) Purchased by OMERS ADMINISTRATION CorpOMERS ADMINISTRATION Corp acquired a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 20,800 shares of the company's stock,May 21, 2025 | marketbeat.comGuardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of CancerMay 20, 2025 | businesswire.comGuardant Health, Inc. (NASDAQ:GH) Shares Sold by Temasek Holdings Private LtdTemasek Holdings Private Ltd lowered its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 25.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,561,979 shares of the company's stMay 20, 2025 | marketbeat.com Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Email Address GH Media Mentions By Week GH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GH News Sentiment▼0.610.90▲Average Medical News Sentiment GH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GH Articles This Week▼168▲GH Articles Average Week Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Natera News Fresenius Medical Care News Hims & Hers Health News Option Care Health News RadNet News BrightSpring Health Services News Sotera Health News Surgery Partners News Privia Health Group News Concentra Group Holdings Parent News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GH) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GH Stock Free GH Stock Alerts